Good MorningEquities ended the month of November on solid footing boosted by remarks by Fed chief Jerome Powell. Mr. Powell signaled the FOMC may shift its stance as soon as the next meeting and slow the pace of interest rate hikes. While the market cheered the news the takeaway is that inflation is still running hot and underpinned by rising wages. In this light, the pace of hikes may have slowed but it is not going to end any sooner than previously indicated. The risk now is that inflation will only subside moderately and prolong the time it takes for the FOMC to do its job.
Today's news may alter the entire FOMC outlook once again so don't be surprised if the market makes an about face. The PCE price index is expected to cool from the previous month but may not have cooled as much as expected. Regardless, the index is expected to support the current outlook for interest rate hikes which is having a negative impact on the outlook for S&P 500 earnings. While this dynamic is overshadowing the market no rally should be trusted. Featured: URGENT: Sell these stocks by December 16th (Behind the Markets) 
|
Markets | | |
Shares of Cosmos Holdings (NASDAQ: COSM) stock are up 618% in November. This penny stock has gone from trading for actual pennies per share to 68 cents per share at the time of this writing. The company has had some favorable news to report. But this has all the earmarks of a short squeeze.
... Read the Full Story |
|
From Our PartnersIn retrospect, what would you have done differently to succeed in the 2022 markets?
Resist the urge to panic sell? Be more diligent in stock analysis? Do away with the emotional roller coaster of volatility?
Trading is tough, but what if I told you that you could use artificial intelligence and be able to forecast up to three days ahead of time what a particular market or security is about to do? | | | | Learn to forecast trends with up to 87.4% proven accuracy -> Register Here |
|
Markets | | | Updated: Federal Reserve Chairman Jerome Powell confirmed Wednesday, Nov 30, that smaller interest rate increases are likely ahead even as he sees progress in the fight against inflation as largely inadequate.We are approaching that time of year when the stock market gets into a holiday mood tr... Read the Full Story |
|
Stocks | | |
Results from Crowdstrike (NASDAQ: CRWD) and NetApp (NASDAQ: NTAP) have brought dark clouds to the cloud-stock universe. While both companies had good CQ3 periods the outlook for the rest of the year is gloomy indeed. The news has both stocks down double digits but this may be an opportunity. Analy... Read the Full Story |
|
From Our PartnersWe are weeks away from the biggest stock market event in more than 70 years.
Certain stocks and cryptocurrencies could drop by 80%.
Bonds and funds could drop even further.
Even your social security check could be worth 21% less. | | | | Here's how to protect yourself > > > |
|
Politics | | | China says president and ruling Communist Party leader Xi Jinping was holding talks Thursday with visiting European Council President Charles Michel in Beijing, amid frictions over trade, Russia and Taiwan.
The official Xinhua News Agency gave no details about the discussions Thursda... Read the Full Story |
|
Politics | | | The U.S. House moved urgently to head off the looming nationwide rail strike on Wednesday, passing a bill that would bind companies and workers to a proposed settlement that was reached in September but rejected by some of the 12 unions involved.
The measure passed by a vote of 290-13... Read the Full Story |
|
From Our PartnersA tiny $4 company has developed a new liquid battery that’s sending shockwaves through the energy industry.
It’s at the center of a “breakthrough,” says The U.S. Department of Energy, that’s a “totally new approach to battery technology.”
Powermag calls it part of the “trillion-dollar holy grail” of battery technology. | | | | Click here for the full story and a 30-second demo |
|
Politics | | | A campaign to vaccinate the elderly has sparked hopes China might roll back severe anti-virus controls that prompted protesters to demand President Xi Jinping resign, but the country faces daunting hurdles and up to a year of hard work before “zero COVID” can end.
Stock markets rose a... Read the Full Story |
|
Politics | | | Sean Turnell, an Australian economist who spent almost two years imprisoned in Myanmar, received a hero’s welcome Thursday at Australia’s Parliament House where lawmakers rose in a standing ovation and the prime minister praised his courage, optimism and resilience.
Turnell, an advise... Read the Full Story |
|
Markets | | | U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal infections.
The Food and Drug Administration on Wednesday approved Rebyota for adults who have trouble ... Read the Full Story |
|
Markets | | |
China-based electric vehicle maker NIO (NYSE: NIO) powered more than 19% higher Wednesday. Shares were trading at $12.51 with an hour left in the session.
NIO, along with other Chinese EV manufacturers, rose in tandem with XPeng (NYSE: XPEV), which reported a third-quarter loss of $0.36, me... Read the Full Story |
|
Stocks | | |
In what has been a tough year for growth investors, few equity categories have provided the spark counted on for portfolio appreciation. The energy sector is one, but it's a sea of red almost everywhere else.
This means two things: 1) many brokerage accounts will be limping into 2023 with lower v... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia. | | View Today's Stock Pick |
|
